Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 30–30 | Cite as

Sequencing for maturity-onset diabetes of the young cost saving

Clinical study
  • 3 Downloads

Reference

  1. Johnson SR, et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care : 6 Dec 2018. Available from: URL: http://doi.org/10.2337/dc18-0261

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations